Market Tracker

07/01 11:17am ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

0.5477
Delayed Data
As of Jun 30
 0.00 / 0.00%
Today’s Change
0.44
Today|||52-Week Range
3.72
-38.97%
Year-to-Date
Sunesis Pharmaceuticals (SNSS) in Focus: Stock Gains 8.7%
Jun 21 / Zacks.com - Paid Partner Content
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.55
Today’s openn.a.
Day’s range0.55 - 0.60
Volume200
Average volume (3 months)244,611
Market cap$47.6M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)+34.21%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-46.62%
P/E ratioNM
Price/Sales21.38
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc0.000.00%
AXNAoxing Pharmaceutica...0.000.00%
CASICASI Pharmaceuticals...0.000.00%
IMMYImprimis Pharmaceuti...0.000.00%
Data as of 06/30/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$3.1M
Annual profit (last year)-$36.7M
Net profit margin-1,198.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts